Evidence map›Paper›PMID 41257138›Full record

ArticleCureus2025

The Traffic Light Planning Algorithm for Breast Augmentation Mastopexy: A Case Series Analysis on Optimizing Early Ptosis.

Amit Nijran, Stephen Ali, Mohamed Maklad

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Amit NijranPlastic Surgery, Queen Elizabeth Hospital Birmingham, Birmingham, GBR.
Stephen AliReconstructive Surgery/Regenerative Medicine Research Centre, Swansea University, Swansea, GBR.
Mohamed MakladPlastic Surgery, Enhance Medical Group, Birmingham, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Breast augmentation is one of the most commonly performed aesthetic procedures, yet cases involving breast ptosis often require a more individualized approach. Determining the optimal strategy for combining augmentation with lift procedures can be challenging, particularly for surgeons early in their aesthetic practice. This study introduces the Traffic Light Planning Algorithm as a structured and objective framework to assess breast anatomy, guide implant positioning, and determine the need for adjunctive lift procedures. The algorithm categorizes patients into three groups (green, amber, and red) to help select the most appropriate management plan. This paper focuses on the amber zone, representing cases with early ptosis, which often present the greatest challenge in achieving optimal correction. Objectives The primary aim of this study was to evaluate the safety and patient satisfaction outcomes associated with the Traffic Light Planning Algorithm over five years (2018-2023). The secondary objective was to conduct a focused retrospective case series analysis of the "amber zone" over 12 months (December 2022-December 2023). This subset analysis aimed to assess whether Mentor MemoryGel Xtra implants (Mentor Worldwide LLC, Irvine, CA, USA) could correct early ptosis without adjunctive mastopexy and to provide supporting evidence for the validity of the algorithm. A representative case report is also included to illustrate the practical application of this approach. Methods A comprehensive description of the algorithm is provided. Over the five-year study period, patient satisfaction, complication rates, and revision rates were analyzed. The 12-month subset analysis further explored patient satisfaction and various patient and surgical factors through cross-tabulation. This retrospective study design was appropriate for assessing real-world outcomes related to patient satisfaction and complications associated with this new structured planning algorithm. The Likert scale was used as an effective tool for evaluating patient satisfaction. Results During the study period, 9,000 breast consultations and 3,000 implant surgeries were performed by the senior author (MM). Overall, 93% of patients reported high satisfaction with their outcomes, with low revision rates of 2% for primary augmentations and 6% for augmentation mastopexies. This method proved particularly effective for cases of early ptosis, providing a structured and reproducible decision-making framework. The subset case series of 59 patients over a 12-month period showed high satisfaction levels: 54 (91.5%) were "very happy," 3 (5.1%) were "happy," 1 (1.7%) was "satisfied," and 1 (1.7%) was "not happy." Complications were reported in four cases (6.8%), including bilateral bottoming out, two cases of implant loss due to infection, and one case of unilateral capsular contracture. The remaining 55 patients (93.2%) experienced no postoperative complications. Conclusions The algorithm provides a reliable and objective framework for planning breast augmentation, particularly valuable for surgeons new to aesthetic practice. By promoting personalized, tissue-based surgical planning, this approach helps minimize complications and enhance patient satisfaction. The case series further demonstrates that applying the algorithm, together with the use of Mentor MemoryGel Xtra implants, can offer an effective strategy for avoiding mastopexy in appropriately selected amber zone patients.

Indexed as

aesthetic surgeriesaugmentation mastopexybreast plastic surgeryplanning algorithmplastic and reconstructive surgery

Identifiers

PMID41257138
PMCPMC12620097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.